MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,069,000 | +25.1% | 17,350 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $35,221,000 | -6.0% | 17,350 | 0.0% | 0.02% | +25.0% |
| Q4 2019 | $37,476,000 | +40.3% | 17,350 | 0.0% | 0.01% | +33.3% |
| Q3 2019 | $26,719,000 | -62.9% | 17,350 | 0.0% | 0.01% | -65.4% |
| Q2 2019 | $72,003,000 | -0.7% | 17,350 | 0.0% | 0.03% | +4.0% |
| Q1 2019 | $72,523,000 | +45.6% | 17,350 | 0.0% | 0.02% | +31.6% |
| Q4 2018 | $49,795,000 | – | 17,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|